Follow
Bin Gui
Bin Gui
Ribon Therapeutics
Verified email at ribontx.com
Title
Cited by
Cited by
Year
Binding of the JmjC demethylase JARID1B to LSD1/NuRD suppresses angiogenesis and metastasis in breast cancer cells by repressing chemokine CCL14
Q Li, L Shi, B Gui, W Yu, J Wang, D Zhang, X Han, Z Yao, Y Shang
Cancer research 71 (21), 6899-6908, 2011
1792011
JMJD6 promotes colon carcinogenesis through negative regulation of p53 by hydroxylation
F Wang, L He, P Huangyang, J Liang, W Si, R Yan, X Han, S Liu, B Gui, ...
PLoS biology 12 (3), e1001819, 2014
1312014
Destabilizing LSD1 by Jade-2 promotes neurogenesis: an antibraking system in neural development
X Han, B Gui, C Xiong, L Zhao, J Liang, L Sun, X Yang, W Yu, W Si, R Yan, ...
Molecular cell 55 (3), 482-494, 2014
1062014
Role of MTA1 in cancer progression and metastasis
N Sen, B Gui, R Kumar
Cancer and Metastasis Reviews 33, 879-889, 2014
1042014
Corepressor protein CDYL functions as a molecular bridge between polycomb repressor complex 2 and repressive chromatin mark trimethylated histone lysine 27
Y Zhang, X Yang, B Gui, G Xie, D Zhang, Y Shang, J Liang
Journal of Biological Chemistry 286 (49), 42414-42425, 2011
812011
Selective targeting of PARP-2 inhibits androgen receptor signaling and prostate cancer growth through disruption of FOXA1 function
B Gui, F Gui, T Takai, C Feng, X Bai, L Fazli, X Dong, S Liu, X Zhang, ...
Proceedings of the National Academy of Sciences 116 (29), 14573-14582, 2019
802019
PARP7 negatively regulates the type I interferon response in cancer cells and its inhibition triggers antitumor immunity
JM Gozgit, MM Vasbinder, RP Abo, K Kunii, KG Kuplast-Barr, B Gui, AZ Lu, ...
Cancer Cell 39 (9), 1214-1226. e10, 2021
772021
Neurodegeneration-associated TDP-43 interacts with fragile X mental retardation protein (FMRP)/Staufen (STAU1) and regulates SIRT1 expression in neuronal cells
Z Yu, D Fan, B Gui, L Shi, C Xuan, L Shan, Q Wang, Y Shang, Y Wang
Journal of Biological Chemistry 287 (27), 22560-22572, 2012
752012
The histone modifications governing TFF1 transcription mediated by estrogen receptor
Y Li, L Sun, Y Zhang, D Wang, F Wang, J Liang, B Gui, Y Shang
Journal of Biological Chemistry 286 (16), 13925-13936, 2011
692011
ZIP: a novel transcription repressor, represses EGFR oncogene and suppresses breast carcinogenesis
R Li, H Zhang, W Yu, Y Chen, B Gui, J Liang, Y Wang, L Sun, X Yang, ...
The EMBO Journal 28 (18), 2763-2776, 2009
602009
Physiological functions of MTA family of proteins
N Sen, B Gui, R Kumar
Cancer and Metastasis Reviews 33, 869-877, 2014
532014
Functional roles and potential clinical application of miRNA‐345‐5p in prostate cancer
I Tinay, M Tan, B Gui, L Werner, AS Kibel, L Jia
The Prostate 78 (12), 927-937, 2018
502018
Enabling drug discovery for the PARP protein family through the detection of mono-ADP-ribosylation
AZ Lu, R Abo, Y Ren, B Gui, JR Mo, D Blackwell, T Wigle, H Keilhack, ...
Biochemical Pharmacology 167, 97-106, 2019
392019
Androgen receptor-mediated downregulation of microRNA-221 and-222 in castration-resistant prostate cancer
B Gui, CL Hsieh, PW Kantoff, AS Kibel, L Jia
PLoS One 12 (9), e0184166, 2017
392017
Targeting the MIF/CXCR7/AKT signaling pathway in castration-resistant prostate cancer
S Rafiei, B Gui, J Wu, XS Liu, AS Kibel, L Jia
Molecular Cancer Research 17 (1), 263-276, 2019
352019
Androgen receptor‐regulated miRNA‐193a‐3p targets AJUBA to promote prostate cancer cell migration
L Jia, B Gui, D Zheng, KF Decker, I Tinay, M Tan, X Wang, AS Kibel
The Prostate 77 (9), 1000-1011, 2017
352017
Secretory leukocyte protease inhibitor is a survival and proliferation factor for castration-resistant prostate cancer
D Zheng, B Gui, KP Gray, I Tinay, S Rafiei, Q Huang, CJ Sweeney, ...
Oncogene 35 (36), 4807-4815, 2016
332016
Rare Variation in TET2 Is Associated with Clinically Relevant Prostate Carcinoma in African Americans
DC Koboldt, KL Kanchi, B Gui, DE Larson, RS Fulton, WB Isaacs, A Kraja, ...
Cancer Epidemiology, Biomarkers & Prevention 25 (11), 1456-1463, 2016
272016
CRISPR screens reveal genetic determinants of PARP inhibitor sensitivity and resistance in prostate cancer
T Tsujino, T Takai, K Hinohara, F Gui, T Tsutsumi, X Bai, C Miao, C Feng, ...
Nature Communications 14 (1), 252, 2023
262023
Identification of a 35S U4/U6. U5 tri-small nuclear ribonucleoprotein (tri-snRNP) complex intermediate in spliceosome assembly
Z Chen, B Gui, Y Zhang, G Xie, W Li, S Liu, B Xu, C Wu, L He, J Yang, X Yi, ...
Journal of Biological Chemistry 292 (44), 18113-18128, 2017
232017
The system can't perform the operation now. Try again later.
Articles 1–20